Veru's Covid-19 drug lowers mortality by 55% in Phase III trial
Veru has reported interim analysis data from a Phase III trial, where sabizabulin lowered mortality by 55% in hospitalised Covid-19 patients.
Source: clinicaltrialsarena.com
Page 8 - Mitchell Steiner News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mitchell Steiner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mitchell Steiner Today - Breaking & Trending Today
Stocks Mixed, Inflation, Veru, Cisco, Starbucks- 5 Things To Know
Stock futures edge lower, Treasury yields rise ahead of march CPI data; White House braced for 'extraordinarily elevated' March inflation reading; Veru shares surge after impressive Covid treatment data; Cisco shares slide on Morgan Stanley, Citigroup downgrades and Starbucks shares slip after Citigroup downgrade
Source: thestreet.com
New Drug Slashed Deaths Among Patients With Severe Covid, Maker Claims
A late-stage trial was halted after strong early results, according to the company, but the data have not yet been published or peer-reviewed.
Source: nytimes.com
Why Is Veru (VERU) Stock Up 200% Today?
Veru (VERU) stock is taking off on Monday as investors react to recent clinical trial news about the company's Covid-19 treatment.
Source: investorplace.com
Why Veru Stock Skyrocketed Today | The Motley Fool
The biotech's experimental COVID-19 treatment could be a game changer.
Source: fool.com